Exploring Clinical Study Experiences of People With Anorexia Nervosa

Anorexia Nervosa Clinical Trial

Official title:

An Analysis of Participation Trends: Observing Patient Engagement in Anorexia Nervosa Clinical Trials

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06207890
• Other study ID #: 58191532
• Status: Not yet recruiting
• Start date: February 2025
• Est. completion date: February 2027

Study information

• Verified date: January 2024
• Source: Power Life Sciences Inc.
• Contact: Michael B Gill
• Phone: 4159004227
• Email: bask[@]withpower.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The study seeks to delve into the firsthand experiences of patients diagnosed with anorexia nervosa who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals.

By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future anorexia nervosa patients and play an active role in advancing medical research.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 500
• Est. completion date: February 2027
• Est. primary completion date: February 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient has self-identified as planning to enroll in a clinical trial

• Patient has been diagnosed with anorexia nervosa

• Patient is a minimum of 18 years or older

Exclusion Criteria:

• Patient does not understand, sign, and return consent form

• Inability to perform regular electronic reporting

• Patient is pregnant

Related Conditions & MeSH terms

• Anorexia
• Anorexia Nervosa

Locations

Country	Name	City	State
United States	Power Life Sciences	San Francisco	California

Sponsors (1)

Lead Sponsor	Collaborator
Power Life Sciences Inc.

Country where clinical trial is conducted

United States, 

References & Publications (3)

Paolacci S, Kiani AK, Manara E, Beccari T, Ceccarini MR, Stuppia L, Chiurazzi P, Dalla Ragione L, Bertelli M. Genetic contributions to the etiology of anorexia nervosa: New perspectives in molecular diagnosis and treatment. Mol Genet Genomic Med. 2020 Jul;8(7):e1244. doi: 10.1002/mgg3.1244. Epub 2020 May 5. — View Citation

Parpia R, Spettigue W, Norris ML. Approach to anorexia nervosa and atypical anorexia nervosa in adolescents. Can Fam Physician. 2023 Jun;69(6):387-391. doi: 10.46747/cfp.6906387. — View Citation

Walsh BT, Hagan KE, Lockwood C. A systematic review comparing atypical anorexia nervosa and anorexia nervosa. Int J Eat Disord. 2023 Apr;56(4):798-820. doi: 10.1002/eat.23856. Epub 2022 Dec 12. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients who decide to participate in anorexia nervosa clinical trial		3 months
Primary	Rate of patients who remain in anorexia nervosa clinical trial to trial completion		12 months